| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/24/2005 | US20050042254 Aligned scaffolds for improved myocardial regeneration |
| 02/24/2005 | US20050042234 Method |
| 02/24/2005 | US20050042231 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 02/24/2005 | US20050042223 Hybridoma cell line producing anti-CTLA4 (cytotoxic T-lymphocyte antigen 4) antibodies; cancer treatment; biodrugs |
| 02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |
| 02/24/2005 | US20050042216 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 02/24/2005 | US20050042208 Incubating precursor cell capable of differentiating to cytotoxic T cell with antigen presenting cell in presence of substance having binding activity to CD44, fibronectin, regulator of signal emitted by growth factor, and/or inhibitor of binding to growth factor receptor; immunotherapy |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | DE20122302U1 Variante des Modifizierten Vaccinia-Ankara-Virus Modified version of the vaccinia Ankara virus |
| 02/24/2005 | DE10335131A1 Porous carbon moldings, e.g. for catalyst support; insulant, tube membrane, ex or in vivo cell culture substrate or scaffold or implant, are made by molding carbonizable polymer and removing filler or partial oxidation to form pores |
| 02/24/2005 | CA2538987A1 A method for improving plant transformation efficiency by adding copper ion |
| 02/24/2005 | CA2536235A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | CA2536146A1 Splice variants of erbb ligands, compositions and uses thereof |
| 02/24/2005 | CA2535685A1 Method of generating neural stem cells |
| 02/24/2005 | CA2535683A1 Stem cell beacon |
| 02/24/2005 | CA2535680A1 Vigilant cells |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2535508A1 A new class of .alpha.2.delta. calcium channel subunits |
| 02/24/2005 | CA2533830A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | CA2532027A1 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | CA2526120A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | CA2524737A1 Antibodies that immunospecifically bind to trail receptors |
| 02/24/2005 | CA2524305A1 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/23/2005 | EP1508619A1 Novel promoter |
| 02/23/2005 | EP1508614A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/23/2005 | EP1508613A2 Modified reconstituted basement membrane composition for assay system |
| 02/23/2005 | EP1508047A2 Method for identifying immunoreactive peptides |
| 02/23/2005 | EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof |
| 02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |
| 02/23/2005 | EP1507865A2 The frog prince, a transposon vector for gene transfer in vertebrates |
| 02/23/2005 | EP1507864A1 A method for production of plants with suppressed photorespiration and improved co2 fixation |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507850A1 A method for generating antigen-presenting cells |
| 02/23/2005 | EP1507849A1 Methods and compositions for expanding and differentiating insulin-producing cells |
| 02/23/2005 | EP1507848A1 Expansion and transdifferentiation of human acinar cells |
| 02/23/2005 | EP1507846A1 Cell culture device |
| 02/23/2005 | EP1507798A1 Export and modification of (poly)peptides in the lantibiotic way |
| 02/23/2005 | EP1507790A2 Human genes and gene expression products isolated from human prostate |
| 02/23/2005 | EP1507561A2 Compositions for delivering nucleic acids to cells |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507552A2 Methods, compositions, and growth and differentiation factors for insulin-producing cells |
| 02/23/2005 | EP1507551A2 The functional role and potential therapeutic use of pacap, vip and maxadilan in relation to adult neural stem or progenitor cells |
| 02/23/2005 | EP1507550A1 Suicide tetramers comprising mhc class i and uses thereof |
| 02/23/2005 | EP1507454A1 Animal model for toxicology and dose prediction |
| 02/23/2005 | EP1315829A4 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
| 02/23/2005 | EP1068311A4 Methods and means for obtaining modified phenotypes |
| 02/23/2005 | EP0783524B1 Peptides and pharmaceutical compositions comprising them |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1585602A Preservation of non embryonic cells from non hematopoietic tissues |
| 02/23/2005 | CN1584036A Method for obtaining transgenic grass for sheep |
| 02/23/2005 | CN1584034A Corn tyrosin protein phosphatase gene and its coding protein and use |
| 02/23/2005 | CN1584020A Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 02/23/2005 | CN1582641A Tetraploid transgenic locust and quick cultivation |
| 02/23/2005 | CN1582639A Method for mutagenizing anti-chlorosulfuron somatic mutant of rice |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190445C Process for producing functional silk fibroin and utilization of the same |
| 02/22/2005 | US6858777 Methods for stable transformation of plants |
| 02/22/2005 | US6858716 Drosophila recombination-associated protein and methods for use |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
| 02/22/2005 | US6858712 Cloning and expression of HTLV-III DNA |
| 02/22/2005 | US6858704 Oligopeptide sequences with c-terminal acidic tails (ATS); increased stability in enzymes, foods, medicines and chemical products |
| 02/22/2005 | US6858582 Composition containing porous microparticle impregnated with biologically-active compound for treatment of infection |
| 02/22/2005 | US6858578 Chimeric proteins for use in transport of a selected substance into cells |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858430 Preparing sea water aquaculture of phaeophytic marine alga for generating bioreactor for expression of heterologous polypeptides |
| 02/22/2005 | US6858429 Universal light-switchable gene promoter system |
| 02/22/2005 | US6858428 Nutrient broth for use in the suppression of apoptosis |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858416 Human desaturase gene and uses thereof |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858397 Antibodies specific for native PrPsc |
| 02/22/2005 | US6858395 Diagnoss and treatment of muscular disorders; obtain tissue sample, detect preferential gene expression, amplified transcription of prferential gene indicates muscular disorder |
| 02/22/2005 | US6858382 Detection systems for registering protein interactions and functional relationships |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/22/2005 | US6858207 Methods and materials relating to novel CD39-like polypeptides |
| 02/22/2005 | US6858146 Artificial liver apparatus and method |
| 02/22/2005 | CA2093022C Targeted immunostimulation with bispecific reagents |
| 02/22/2005 | CA2071543C Recombinant dna method and vectors for use therein |
| 02/19/2005 | CA2457296A1 Methods for inducing differentiation of pluripotent cells |
| 02/17/2005 | WO2005015151A2 Method for purifying mesenchymal stem cells |
| 02/17/2005 | WO2005014838A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/17/2005 | WO2005014836A2 Chimaeric vector system |
| 02/17/2005 | WO2005014826A1 Use of npabc1 transporter and promoter thereof |
| 02/17/2005 | WO2005014802A1 Method for culturing avian spermatogonial stem cells and avian spermatogonial stem cells prepared thereby |
| 02/17/2005 | WO2005014801A1 Improvements in cell culture productivity |
| 02/17/2005 | WO2005014800A1 Myeloma cell culture in transferrin-free low iron medium |
| 02/17/2005 | WO2005014799A1 Conditioned cell culture medium, method to obtain the same and use of it for maintenance, proliferation and differentiation of mammalian cells |
| 02/17/2005 | WO2005014788A2 Tssk4: a human testis specific serine/threonine kinase |
| 02/17/2005 | WO2005014787A2 Genetic elements conferring flower petal-specific transgene expression |
| 02/17/2005 | WO2005014785A2 Conditionally-immortalized hematopoietic progenitor cell lines |
| 02/17/2005 | WO2005014774A1 Carrier for culturing animal cell, and method for culturing or transplanting animal cell using said carrier for culture |
| 02/17/2005 | WO2005014615A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/17/2005 | WO2005014149A1 Composite porous membrane and process for producing the same |
| 02/17/2005 | WO2005014070A1 Method of bone regeneration |
| 02/17/2005 | WO2005014016A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | WO2005014015A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | WO2005013912A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 02/17/2005 | WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | WO2005013895A2 Compositions and methods for the treatment of schizophrenia and addictive disorders |